In 2020, local activist and former drug user Peter Krykant decided that he had had enough of seeing people dying from drug overdoses in his home town of Glasgow. So he took it upon himself to set up and operate an unsanctioned harm-reduction service. He kitted out a minivan, and later a former ambulance, to provide a mobile overdose-prevention service. He did so openly in defiance of the law and was arrested, only for the charges to be dropped. Five years later, The Thistle, the first safe consumption room in the UK, opened in Glasgow. Sadly, Krykant passed away just a few months later.
If there is a consensus on drug harms, it is that the current way the UK deals with them is failing. Scotland recently recorded its highest-ever number of annual drug deaths: 1,133 – an 11 per cent rise on the previous year. It is the country with the worst fatality rate from drugs in Europe. In England and Wales, the picture is little better, with drug deaths rising annually in recent years to reach 5,565 deaths in 2024, the last year for which public information is available.
Scotland took the step of opening the first “safe consumption” facility in the UK in an attempt to reduce the harms caused by substances such as heroin and fentanyl. People bring their drugs and can use them under supervision with provided clean equipment, meaning that if they overdose, medical intervention can happen immediately.
Around 800 people have used the service to administer over 16,000 injections in the 18 months it has been open. “We’re sited within an area that has a very high prevalence of problem drug use, and that has historically been known to experience people who inject away from home in public places. So that helps us in terms of making it accessible for people who use drugs,” said Dr Saket Priyadarshi, associate medical director, alcohol and drug recovery services, at NHS Greater Glasgow and Clyde.
In that time, Priyadarshi and his staff have been able to provide immediate and often life-saving medical assistance on over 200 occasions to people who have overdosed.
“I think the other strong area of learning for us has been the really dynamic and toxic nature of the drug market – and what a risk that is for people who use drugs,” Priyadarshi said. While the service initially saw a lot of cocaine use, that shifted to heroin and more recently to heroin adulterated with the synthetic opioids known as nitazenes.
Beyond its role in safe consumption and overdose prevention, The Thistle acts as an access point to a range of healthcare and other services that people might otherwise not access. These include those for housing, wound care, sexual health, blood-borne diseases and getting support and treatment for drug use.
“We know of really positive cases where people have moved on in their lives quite significantly, including moving on to recovery communities and residential rehab,” Priyadarshi said.
Harm reduction itself is not a new concept, but it is an approach that historically has been driven by people with lived experience. One well-known example is programmes to provide clean needles to people who inject drugs in order to reduce the transmission of HIV and hepatitis C associated with sharing needles. These started in the mid-1980s with activist groups of drug users in Amsterdam working with the local government, before being adopted more widely as a way to curb the HIV/AIDS pandemic.
To date, there has yet to be a single death, not just in The Thistle but in any of the over 100 safe consumption rooms globally since the first one opened in Switzerland in 1986. Across that timespan, the harm reduction approach has expanded to include a variety of methods to help people reduce the harm to themselves and others from their drug use without criminalising them. That includes overdose prevention, providing safe equipment and even ensuring a safe supply of drugs. A small number of areas in the UK now provide drug-checking services where people can see and understand what they are about to take and what it may have been cut or adulterated with.
Lanre Babalola was a service user at the Drug Advisory Service in Haringey, north London. It was the early 2000s and he and fellow service users felt that, when their 12 week programme ended, their needs had still not been met. They went on to establish a “lived experience recovery organisation” (LERO) called Bringing Unity Back Into the Community (BUBIC), an organisation for people who use drugs established and run by people with lived experience
of recovery.
Their aim was to go where no other service would, working out of hours, going into crack houses and working through peer support with people whom traditional clinical services would judge to be “too difficult”, and standing with people in their journey towards recovery.
“Peer support is a thing where people identify ‘I’ve been through it. You’ve been through it. I’ll use what I’ve had to support you’, and it’s not clinical language. It’s not a treatment language. It’s lived experience,” Babalola said.
For Babalola, the key role of harm reduction is to give people the opportunity and space to address the reasons why they use drugs. Often that includes trauma, undiagnosed or supported neurodivergence and mental health conditions. These are issues that cannot be addressed through a time-limited 12-week programme. Babalola would like to see more bespoke services, particularly to support people who use crack, and better understanding, awareness and recruitment of people who are neurodivergent. “When we started, we started for us, by us black people because we were marginalised, we were the hard-to-engage group,” he said.
The other significant harm comes from the crime associated with drugs. One person who has fundamentally changed his view on this is Neil Woods, a former undercover police officer who spent years working to smash drug-dealer networks only to find these efforts were largely futile and served to escalate the harms.
“[Harm reduction] doesn’t just save lives; it also reduces crime, because if you stabilise somebody’s life and you protect them from the exploitation of organised crime, those people are not being exploited to commit further crime to fuel an addiction,” he said.
Woods is an advocate for heroin-assisted treatment, a legal but relatively expensive way to reduce the harm for heroin users by providing a safe supply of the drug under clinical supervision – and one which he points out would cost around a fifth of the outlay for incarcerating someone for a year.
Woods would go further policy-wise into the safe supply of other drugs in order to reduce the harm to children who are exploited by criminal gangs in order to sell drugs, including the “county lines” model used by gangs. “Police never reduce the size of the market; they only change the shape of the market, and that changing shape in the UK has meant an explosion of child exploitation,” he said.
Up until the 1960s, the UK approach to addiction was to treat it as a health issue, Woods explains. “We used to lead the world in drug policy, which meant that if you developed a problem with drugs, you went to the doctor and got help,” he said.
When the UK changed that policy and took a criminalised approach, the number of people regularly using heroin went from just over 1,000 to over 300,000 in 15 years. The problem, he says, is that the debate on drugs reform and harm reduction has been “poisoned” by “ideological nonsense”.
“We don’t need a change in the law for this, and it’s the single change in drug policy that would make a bigger difference than anything,” Woods said.
Harm reduction and broader drugs reform does have advocates in parliament. Jeff Smith MP, chair of the All-Party Parliamentary Group for Drug Policy Reform, believes that “successive governments have been just too timid in engaging with drug policy”.
This, he says, is because of the fear politicians have of being out of step with public opinion. On top of that, the media have historically “weaponised” any attempt by government to pursue policies that are seen as soft on drugs.
Smith says it is a “frustration” that the current government claims that it will follow evidence but does not appear to be willing to do this around harm reduction, particularly on the case for rolling out more safe consumption rooms. “It does appear as though the government have already made up their mind on this and don’t want to get involved with it,” he said.
In Bristol, the city council is working towards becoming a “city of harm reduction”. The work is led by Cara Lavan, a Green Party councillor whose partner died of an overdose in 2014 and who has long campaigned for better support for people who use drugs. “Bristol’s always been a very progressive city, and there’s a lot of work that’s gone on for years,” she said.
Lavan’s aim is to push harm reduction further in the city, but she has come up against the constraints of central government policy. That includes legal restrictions on opening a safe consumption room along the lines of The Thistle, which is only allowed to operate because the Scottish Lord Advocate effectively directed the police not to prosecute anyone working there for criminal offences under Scottish law.
“The police also have a certain amount of discretion to decide whether it’s in the public interest to prosecute people,” Lavan explained. This discretion underpins drug diversion schemes, where possession of small amounts of drugs can be dealt with through treatment and rehabilitation rather than criminal sanctions. But discretionary policing also raises questions about unequal treatment, particularly given the disproportionate targeting of black and brown people in drug enforcement.
There is a drug-checking service in the city, one of a handful across the UK, where people can bring their drugs to test what is in them and discover if it has been cut with anything harmful.
Bristol Council has approached the Home Office to ask for permission to establish a safe consumption room similar to The Thistle. However, thus far the Home Office has not shown enthusiasm for expanding the scheme to other cities. The evaluation of The Thistle will not conclude until late 2029, which will determine if it is allowed to continue. If trends continue, England and Wales will have recorded at least another 20,000 deaths by this time.
For Lavan, there is fundamentally a lack of ambition on the part of government when compared to other causes of death. She gives the example of Vision Zero, a strategy to reduce the number of deaths and serious injuries on roads to zero.
Sweden has taken this idea further and applied it to deaths by suicide, aiming to reduce them to zero. By contrast, the Sunak government set a target of preventing 1,000 deaths from drugs in the three years up to 2025 – a period during which drug deaths increased. The Starmer government said it hoped to save “hundreds” of lives by providing the opioid overdose-reversing treatment naloxone to homelessness shelters – a proposal that has still not made it into practice nearly a year later.
“In the context of Labour, we certainly haven’t seen a resistance to harm-reduction interventions that are already permitted under the policy,” said Niamh Eastwood, executive director of Release, a charity that works on drugs law and policy. This is a change from policy under the Coalition and Conservative governments, which prioritised recovery leading to abstinence over harm reduction, she continues. This, Eastwood argues, together with cuts to drug and alcohol services during this period, are key reasons as to why the UK has such a high rate of drug deaths.
Andy Burnham recently rejected one of the more radical proposals available to him, decriminalisation of drugs, which has been the policy in Portugal since 2001 and is supported by the SNP, Plaid, the Green Party (who also advocate for legalisation and regulation of all drugs) and Liberal Democrats to an extent. Compared with the UK, Portugal records around 100 deaths from drugs each year, one of the lowest rates in Europe.
“I think pragmatically that something government could do is give clear signals to local public health commissioners that we need to have low-threshold services, so services where people can walk in through the door and access whether it be OST [opioid substitution therapy] or needle and syringe programmes, or individual support, peer support – those are the kinds of services that we do need to be investing in,” Eastwood said.
Its advocates argue that harm reduction represents an effective and pragmatic response, one which can happen under the UK’s current criminalised approach to drug use.
But attempts to deliver it at scale are still hamstrung by political reticence and lack of willingness to change a system that almost all agree is broken. Until the status quo is changed, we risk thousands of people continuing to die needlessly each year.





